IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v9y2018i1d10.1038_s41467-018-06606-2.html
   My bibliography  Save this article

Aberrant expression of CITED2 promotes prostate cancer metastasis by activating the nucleolin-AKT pathway

Author

Listed:
  • Seung-Hyun Shin

    (Seoul National University College of Medicine
    Seoul National University College of Medicine
    Seoul National University College of Medicine)

  • Ga Young Lee

    (Seoul National University College of Medicine
    Seoul National University College of Medicine
    Seoul National University College of Medicine)

  • Mingyu Lee

    (Seoul National University College of Medicine
    Seoul National University College of Medicine
    Seoul National University College of Medicine)

  • Jengmin Kang

    (Seoul National University College of Medicine
    Seoul National University College of Medicine
    Seoul National University College of Medicine)

  • Hyun-Woo Shin

    (Seoul National University College of Medicine
    Seoul National University College of Medicine
    Seoul National University College of Medicine)

  • Yang-Sook Chun

    (Seoul National University College of Medicine
    Seoul National University College of Medicine)

  • Jong-Wan Park

    (Seoul National University College of Medicine
    Seoul National University College of Medicine
    Seoul National University College of Medicine)

Abstract

Despite many efforts to develop hormone therapy and chemotherapy, no effective strategy to suppress prostate cancer metastasis has been established because the metastasis is not well understood. We here investigate a role of CBP/p300-interacting transactivator with E/D-rich carboxy-terminal domain-2 (CITED2) in prostate cancer metastasis. CITED2 is highly expressed in metastatic prostate cancer, and its expression is correlated with poor survival. The CITED2 gene is highly activated by ETS-related gene that is overexpressed due to chromosomal translocation. CITED2 acts as a molecular chaperone to guide PRMT5 and p300 to nucleolin, thereby activating nucleolin. Informatics and experimental data suggest that the CITED2–nucleolin axis is involved in prostate cancer metastasis. This axis stimulates cell migration through the epithelial–mesenchymal transition and promotes cancer metastasis in a xenograft mouse model. Our results suggest that CITED2 plays a metastasis-promoting role in prostate cancer and thus could be a target for preventing prostate cancer metastasis.

Suggested Citation

  • Seung-Hyun Shin & Ga Young Lee & Mingyu Lee & Jengmin Kang & Hyun-Woo Shin & Yang-Sook Chun & Jong-Wan Park, 2018. "Aberrant expression of CITED2 promotes prostate cancer metastasis by activating the nucleolin-AKT pathway," Nature Communications, Nature, vol. 9(1), pages 1-14, December.
  • Handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-06606-2
    DOI: 10.1038/s41467-018-06606-2
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-018-06606-2
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-018-06606-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-06606-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.